Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 4
2008 3
2009 4
2010 1
2012 1
2013 1
2019 1
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
From pharmacokinetics to therapeutics.
Church MK, Gillard M, Sargentini-Maier ML, Poggesi I, Campbell A, Benedetti MS. Church MK, et al. Among authors: sargentini maier ml. Drug Metab Rev. 2009;41(3):455-74. doi: 10.1080/10837450902891535. Drug Metab Rev. 2009. PMID: 19601722 Review.
Physiologically based pharmacokinetics (PBPK).
Espié P, Tytgat D, Sargentini-Maier ML, Poggesi I, Watelet JB. Espié P, et al. Among authors: sargentini maier ml. Drug Metab Rev. 2009;41(3):391-407. doi: 10.1080/10837450902891360. Drug Metab Rev. 2009. PMID: 19601719 Review.
Brivaracetam disposition in renal impairment.
Sargentini-Maier ML, Sokalski A, Boulanger P, Jacobs T, Stockis A. Sargentini-Maier ML, et al. J Clin Pharmacol. 2012 Dec;52(12):1927-33. doi: 10.1177/0091270011431457. Epub 2012 Jan 10. J Clin Pharmacol. 2012. PMID: 22235139 Clinical Trial.
Pharmacokinetics of levetiracetam XR 500mg tablets.
Rouits E, Burton I, Guénolé E, Troenaru MM, Stockis A, Sargentini-Maier ML. Rouits E, et al. Among authors: sargentini maier ml. Epilepsy Res. 2009 Apr;84(2-3):224-31. doi: 10.1016/j.eplepsyres.2009.02.001. Epub 2009 Mar 4. Epilepsy Res. 2009. PMID: 19264451 Clinical Trial.
Brivaracetam disposition in mild to severe hepatic impairment.
Stockis A, Sargentini-Maier ML, Horsmans Y. Stockis A, et al. Among authors: sargentini maier ml. J Clin Pharmacol. 2013 Jun;53(6):633-41. doi: 10.1002/jcph.82. Epub 2013 May 3. J Clin Pharmacol. 2013. PMID: 23649964 Clinical Trial.
15 results